Change Country
Welcome to BelgiumWelcome
Please read the important information below before continuing to our website

The Lyxor ETFs on this website may be restricted for certain individuals or in certain countries pursuant to the national regulations applicable to those individuals or countries. It is therefore your responsibility to ensure that you are authorised to invest in the Lyxor ETFs on this website. 

 

If you are an investor in the United Kingdom, please go to www.lyxoretf.co.uk  

If you are an investor in the Netherlands, please go to www.lyxoretf.nl  

If you are an investor in Italy, please go to www.lyxoretf.it  

If you are an investor in Spain, please go to www.lyxoretf.es  

If you are an investor in Austria, please go to www.lyxoretf.at  

If you are an investor in Germany, please go to www.lyxoretf.de   

If you are an investor in Singapore, please go to www.lyxoretf.com.sg  

If you are an investor in Switzerland, please go to www.lyxoretf.ch  

If you are an investor in Belgium, please go to www.lyxoretf.be  

If you are an investor in Poland, please go to www.lyxoretf.pl 

If you are an investor in Norway, please go to www.lyxoretf.no

If you are an investor in Denmark, please go to www.lyxoretf.dk

If you are an investor in Luxembourg, please go to www.lyxoretf.lu

If you are an investor in Sweden, please go to www.lyxoretf.se

If you are an investor in Finland, please go to www.lyxoretf.fi

 

 

The Lyxor ETFs on this website are undertakings for collective investment in transferable securities (UCITS) (i) domiciled in France and approved by the Autorité des Marchés Financiers (AMF) or, (ii) domiciled in Luxembourg, approved by the Commission de Surveillance du Secteur Financier (CSSF) and authorised to market their units or shares in the French Republic in accordance with the notification procedure under Article 93 of Directive 2009/65/EC. Investors should note that the prospectuses of certain Lyxor ETFs under Luxembourg law that have been notified in accordance with this procedure are only available on the website in English. A French translation of these prospectuses can be obtained upon request by sending a letter to Lyxor International Asset Management (“Lyxor”) – 17 Cours Valmy, 92987 Paris La Défense, France.

 

The information on this website is not intended for persons or entities that are resident, located or registered in jurisdictions that are not authorised to distribute Lyxor ETFs. As a result, the information on this website does not constitute an offer or solicitation to buy or sell units or shares in these ETFs by anyone in any jurisdiction:

 

(a)   in which such an offer or solicitation is unauthorised;

(b)   in which Lyxor is not qualified to make such an offer or solicitation; or 

(c)   in which it is unlawful to make such an offer or solicitation.

 

In particular, the Lyxor ETFs on this website are not and will not be registered under the United States Securities Act of 1933, as amended. As such, they may not be offered or sold within the United States of America, except in specific cases where transactions are exempt from registration under the Securities Act. The ETFs listed on this website may not be sold to US citizens or transferred to the United States by any other means, unless this transaction is not subject to any specific registration under US law. 

 

Any person from a jurisdiction to which the above-mentioned restrictions apply should inform themselves of and observe these restrictions.

 

This website is intended for commercial purposes and is not regulatory in nature. Although the information provided has been drawn up on the basis of sources considered to be reliable, there is no guarantee that it is accurate, complete or relevant. Some of the information on this website is provided on the basis of market data collected at a specific time and may therefore vary over time. Lyxor advises investors to read the risk factors section of the prospectus and the key investor information document carefully. These documents can be found on the website.

 

The net asset value (“NAV”) of Lyxor ETFs may at any time be subject to considerable price fluctuations, which in some cases may lead to the loss of all of the capital invested. Investors should note that some ETFs may be sensitive to fluctuations in the exchange rate between their reference currency and that of the underlying index, as well as of the components of the underlying index.

 

Before investing in a Lyxor ETF, you should carry out your own risk analysis of the product from a legal, tax and accounting perspective, rather than basing your decision solely on the information provided. If necessary, you should consult your own advisers or any other qualified professional. 

 

Subject to compliance with the legal obligations by which they are bound, Lyxor or any entity within the same group shall not be held liable for any financial or other consequences of an investment in the product. 

 

 

By clicking on institutional or individual above, I confirm that I have read and understood the information provided herein, and that I am resident or registered in Belgium.

17 Nov 2017

1 down, 3 to go – Donald’s first 365 days 

 

7 November marked a year to the day that Donald Trump was handed the keys to the kingdom on the US. It’s safe to say it’s been a whirlwind ride since then. The equity markets however have enjoyed some much plainer sailing, but what lies ahead?

 

Break on through

Not for the first time this year, the S&P 500 has breached its all-time high – a fact that’s easy to overlook given the negative headlines that have plagued the US’s divisive Commander-in-Chief. Yet investors still seem content to price in many of his promises (tax cut, cash repatriation, deregulation, investment plan) and have benefited from a “Goldilocks” scenario: fairly strong growth with low bond yields and a weak dollar.  

 

Promises vs. prices

Clearly, fundamentals remain impressive and some risks have passed – for now at least it looks less likely the Trump presidency will fail despite all the wailing and gnashing of teeth. The debt ceiling has been raised, at least until 8 December, and tax reform finally appears to be under way. 

Promises vs. prices

Tax cut fight

There will, undoubtedly, be some opposition to overcome – notably from small businesses – so changes are likely, but the GOP should still be able to pass a bill by the end of the year. This will be a huge relief to those investors who’ve been betting on deep tax cuts and driving the S&P 500 ever higher.

It will also be a huge relief to the President, whose policymaking apprenticeship has been troubled to say the least. After the healthcare debacle, he is in desperate need of a major legislative victory to conclude his first year in office. So far, the much-promised fiscal push has, rather ironically, met a bureaucratic brick wall.  

 

Jerome joins Janet’s dots

We do have the name of the new Fed Chair – the centrist, down-to-earth Jerome Powell will take office in February, once Janet Yellen’s term comes to an end. Whilst not the most ardent proponent of de-regulation on the shortlist, Powell has stated his desire to lighten the regulatory load, especially on smaller banks. 

He’s also likely to tread the familiar, gradual path of normalisation laid down by his predecessor. At least, that’s what the market – which received his nomination warmly - is hoping for. Continuity is king on Wall Street. Any deviation from that path could expose the true scale of the equity market’s vulnerability to Fed balance sheet reduction.

Still, decent growth and little in the way of wage pressure is translating into solid margins, which in turn fuels firmer earnings per share growth as has been amply demonstrated by the results of the current earnings season to date. Positive surprises have been plentiful. In truth then, it‘s all suggestive of a very conducive environment for equities. And many investors do seem to believe the run will continue, at least for another 12-18 months until the economy starts slowing, because they can’t see any more catalysts for change. 

 

No more than neutral

Yet the S&P 500 is up by 20%+ over the last 12 months, which looks stretched to us.  We’re neutral overall on US equities and feel the need to be more selective than the headline figures suggest. Details on tax reform are sketchy, but the odds of an accord seem to have increased. Looming mid-terms add to the pressure for the Republicans. Sector calls are difficult at this stage, but we do expect domestic-focused areas to benefit most. We still favour large-caps over their smaller peers as well. We’re bullish on banks over the long term, given the prospects for de-regulation, but low inflation could prove a headwind for a while yet.

Risk Warning 

It is important for potential investors to evaluate the risks described below and in the fund prospectus which can be found on www.lyxoretf.com

CAPITAL AT RISK: ETFs are tracking instruments: Their risk profile is similar to a direct investment in the Underlying Index. Investors’ capital is fully at risk and investors may not get back the amount originally invested.

REPLICATION RISK: The fund objectives might not be reached due to unexpected events on the underlying markets which will impact the index calculation and the efficient fund replication.

COUNTERPARTY RISK: Investors are exposed to risks resulting from the use of an OTC Swap with Societe Generale. In-line with UCITS guidelines, the exposure to Societe Generale cannot exceed 10% of the total fund assets. Physically replicated ETFs may have counterparty risk resulting from the use of a Securities Lending Programme.

UNDERLYING RISK: The Underlying Index of a Lyxor ETF may be complex and volatile. When investing in commodities, the Underlying Index is calculated with reference to commodity futures contracts exposing the investor to a liquidity risk linked to costs such as cost of carry and transportation. ETFs exposed to Emerging Markets carry a greater risk of potential loss than investment in Developed Markets as they are exposed to a wide range of unpredictable Emerging Market risks.

CURRENCY RISK: ETFs may be exposed to currency risk if the ETF is denominated in a currency different to that of the Underlying Index they are tracking. This means that exchange rate fluctuations could have a negative or positive effect on returns.

 LIQUIDITY RISK: Liquidity is provided by registered market-makers on the respective stock exchange where the ETF is listed, including Societe Generale. On exchange liquidity may be limited as a result of a suspension in the underlying market represented by the Underlying Index tracked by the ETF; a failure in the systems of one of the relevant stock exchanges, Societe Generale or other market-maker systems; or an abnormal trading situation or event.This document is for the exclusive use of investors acting on their own account and categorized either as “eligible counterparties” or “professional clients” within the meaning of Markets in Financial Instruments Directive 2004/39/EC. It is not directed at retail clients. In Switzerland, it is directed exclusively at qualified investors.

Research Disclaimer

Lyxor International Asset Management (“LIAM”) or its employees may have or maintain business relationships with companies covered in its research reports. As a result, investors should be aware that LIAM and its employees may have a conflict of interest that could affect the objectivity of this report. Investors should consider this report as only a single factor in making their investment decision.

Connect with us on linkedin